non-insulin-dependent diabetes


Also found in: Dictionary, Thesaurus, Acronyms.
Related to non-insulin-dependent diabetes: type 2 diabetes, Diabetes mellitus type 2

non-insulin-dependent diabetes

or

non-insulin-dependent diabetes mellitus

(nŏn-ĭn′sə-lĭn-dĭ-pĕn′dənt)
References in periodicals archive ?
Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients.
Demographics and clinical characteristics of 126 patients with non-insulin-dependent diabetes mellitus Men (n = 56) Age (years) 64.
Although insulin-dependent diabetes strikes mostly youngsters, the disease seldom occurs in children under the age of one, and non-insulin-dependent diabetes is most often an affliction of middle and old age.
Blonde L, Guthrie RD, Sandberg MI: Glucophage: an effective and safe agent for initial monotherapy in patients with non-insulin-dependent diabetes mellitus.
Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial.
A recently published consensus document on the management of non-insulin-dependent diabetes (the commonest type in elderly subjects) warns us not to 'overtreat' our elderly patients [2], but the authors are unable to define what they mean by 'elderly'.
Manson JE, Rimm EB, Stampfer MJ, et al: Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus.
As a result, they may be prone to type II, or non-insulin-dependent diabetes, in which the overworked pancreas can't supply enough insulin to satisfy the body's demand.
This sounds an ideal combination of effects and we shall have to wait and see whether this hormone or a modification of it is ever marketed for the treatment of non-insulin-dependent diabetes.
Type 2 diabetes, previously known as adult-onset diabetes or non-insulin-dependent diabetes mellitus (NIDDM), accounts for 90-95% of diagnosed diabetes cases globally and typically develops in middle-aged adults.
In the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM), funded by Bayer AG, 1,429 subjects aged 40-70 years with impaired glucose tolerance were randomized to receive 100 mg acarbose or placebo three times daily for a mean 3.

Full browser ?